Tower Research Capital LLC (Trc) Sellas Life Sciences Group, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $4.87 Billion
  • Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,305 shares of SLS stock, worth $6,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,305
Previous 3,709 43.03%
Holding current value
$6,843
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$0.84 - $1.35 $1,340 - $2,154
1,596 Added 43.03%
5,305 $5,000
Q3 2024

Nov 14, 2024
SELL
$1.08 - $1.39 $10,715 - $13,791
-9,922 Reduced 72.79%
3,709 $4,000
Q2 2024

Aug 13, 2024
SELL
$1.06 - $1.63 $7,519 - $11,563
-7,094 Reduced 34.23%
13,631 $16,000
Q1 2024

May 15, 2024
BUY
$0.51 - $1.55 $7,839 - $23,825
15,371 Added 287.09%
20,725 $20,000
Q4 2023

Feb 13, 2024
SELL
$0.88 - $1.57 $3,220 - $5,746
-3,660 Reduced 40.6%
5,354 $5,000
Q3 2023

Nov 14, 2023
BUY
$1.42 - $1.83 $2,798 - $3,606
1,971 Added 27.99%
9,014 $14,000
Q2 2023

Aug 14, 2023
SELL
$1.35 - $1.8 $2,069 - $2,759
-1,533 Reduced 17.88%
7,043 $11,000
Q1 2023

May 09, 2023
BUY
$1.18 - $3.86 $8,696 - $28,448
7,370 Added 611.11%
8,576 $12,000
Q4 2022

Feb 10, 2023
SELL
$1.8 - $5.41 $2,655 - $7,979
-1,475 Reduced 55.02%
1,206 $3,000
Q3 2022

Nov 10, 2022
SELL
$2.02 - $3.38 $2,169 - $3,630
-1,074 Reduced 28.6%
2,681 $5,000
Q2 2022

Aug 15, 2022
BUY
$2.14 - $4.15 $7,042 - $13,657
3,291 Added 709.27%
3,755 $8,000
Q1 2022

May 12, 2022
SELL
$4.73 - $7.18 $2,033 - $3,087
-430 Reduced 48.1%
464 $3,000
Q4 2021

Feb 14, 2022
SELL
$5.36 - $9.53 $11,770 - $20,927
-2,196 Reduced 71.07%
894 $5,000
Q3 2021

Nov 15, 2021
BUY
$8.21 - $10.53 $22,290 - $28,588
2,715 Added 724.0%
3,090 $28,000
Q2 2021

Aug 16, 2021
SELL
$7.19 - $13.71 $7,039 - $13,422
-979 Reduced 72.3%
375 $4,000
Q1 2021

May 17, 2021
BUY
$5.5 - $11.71 $473 - $1,007
86 Added 6.78%
1,354 $12,000
Q4 2020

Feb 16, 2021
BUY
$2.45 - $17.66 $1,979 - $14,269
808 Added 175.65%
1,268 $7,000
Q3 2020

Nov 16, 2020
SELL
$1.88 - $3.58 $2,391 - $4,553
-1,272 Reduced 73.44%
460 $1,000
Q2 2020

Aug 13, 2020
BUY
$1.53 - $3.93 $2,649 - $6,806
1,732 New
1,732 $5,000

Others Institutions Holding SLS

# of Institutions
38
Shares Held
7.08M
Call Options Held
1.8M
Put Options Held
49.7K
View Full List

About SELLAS Life Sciences Group, Inc.

SLS Quotes by TradingView
  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $26.5M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email